Jan Lötvall
Jan Lötvall (also spelled Lotvall) is a Swedish clinical allergist and scientist working on translational research primarily in the field of asthma. He is the former director of the Krefting Research Centre at the University of Gothenburg[1] and is the Chief Scientific Officer of ExoCoBio.[2][3]
Lötvall's laboratory proposed extracellular vesicles such as exosomes and microvesicles as shuttles of RNA molecules between cells[4] along with several other groups in 2006,[5] 2007,[6] and 2008.[7]
Lötvall was a member of the Executive Committee of the European Academy of Allergy and Clinical Immunology, its secretary general from 2005 to 2009, and its president from June 2009 to June 2011.[8] Lötvall was also co-editor-in-chief of Respiratory Research from 2003 to 2018.[9] He was the first president of the International Society for Extracellular Vesicles (2012-2016) and chaired the first society meeting in Gothenburg, in April 2012.[10] Lötvall became Editor-in-Chief of Journal of Extracellular Vesicles in 2019.
Lötvall studied medicine at the
References
- ^ "Krefting Steering Committee - Krefting Research Centre, University of Gothenburg, Sweden". Retrieved 2011-01-03.
- ^ "ExoCoBio website".
- ^ "ExoCoBio's First Global Regenerative Aesthetic Exosome Summit". Retrieved 2024-01-15.
- S2CID 8599814.
- S2CID 25723677.
- PMID 17556595.
- PMID 19011622.
- ^ "Executive Committee". European Academy of Allergy and Clinical Immunology. Retrieved 2011-01-03.
- PMID 30477500.
- ^ "Executive Board (2012-2014) | ISEV - International Society for Extracellular Vesicles". ISEV. Archived from the original on 2013-08-05. Retrieved 2012-10-08.
- ^ "ExoCoBio website".
- ^ "ExoCoBio's First Global Regenerative Aesthetic Exosome Summit". Retrieved 2024-01-15.